Torigen Pharmaceuticals

Healthcare SpecialistsSeries AFarmington, UStorigen.com

Latest round

Series A

Last raised

Nov 2022

Total raised

$16M

Investors

10

About Torigen Pharmaceuticals

Based in Connecticut, US, and founded in 2013, Torigen Pharmaceuticals Inc. operates as a Veterinary pharmaceutical company that develops prescription products for veterinary cancer treatment.  The company, regulated by the USDA Center for Veterinary Biologics, specializes in developing an experimental autologous prescription product for veterinary cancer. Torigen’s approach involves creating personalized whole-cell tissue vaccines from a pet’s own deactivated tumor cells, aiming to harness the immune system to combat cancer. Torigen’s core product focuses on generating specific adaptive immunity to tumor-associated antigens and its vaccines are applicable to a variety of cancers. These treatments can be administered alone or alongside traditional therapies like chemotherapy and radiation, making them versatile and practical for different clinical settings. As of May 2024, more than 1,200 companion animals have been treated with Torigen’s products.

Who invested in Torigen Pharmaceuticals

10 investors across 3 rounds

See all investors in Torigen Pharmaceuticals

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Nov 16, 2022

    Amount

    $13M

    Investors

    Locked

  2. Series A

    Feb 7, 2019

    Amount

    $3.1M

    Investors

    Locked

  3. Seed

    Aug 5, 2018

    Amount

    Undisclosed

    Investors

    Locked

Questions about Torigen Pharmaceuticals

Who invested in Torigen Pharmaceuticals?

Torigen Pharmaceuticals has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Torigen Pharmaceuticals raised?

Torigen Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Torigen Pharmaceuticals last raise money?

Torigen Pharmaceuticals's most recent round on record is a Series A, in Nov 2022.

What does Torigen Pharmaceuticals do?

Based in Connecticut, US, and founded in 2013, Torigen Pharmaceuticals Inc.

Where is Torigen Pharmaceuticals headquartered?

Torigen Pharmaceuticals is headquartered in Farmington, US.

Which VCs invest in companies like Torigen Pharmaceuticals?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare specialists companies at Torigen Pharmaceuticals's stage. Their profiles are linked below.

Raising like Torigen Pharmaceuticals? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.